Search 

Meet MEU at the UK Pavilion (Hall B, Stand 2348).

Medicines Evaluation Unit (MEU) Ltd is one of the UK’s leading CROs, a facility where commitment to excellence is paramount. MEU possess extensive pharmaceutical, scientific and clinical expertise, allied with fast volunteer recruitment, within a state-of-the-art hospital-based research facility.

MEU offer products and services to enable better, safer and more efficient study designs, particularly in complex patient groups. MEU’s bespoke, phenotyped database and trial management system (ICARUS), assists rapid study recruitment ensuring we meet our clients’ timelines. ICARUS possesses over 32,000 active volunteer profiles and enables MEU to assess protocol inclusion criteria, and accurately provide real-time feasibility.

MEU has a team of experienced Principal Investigators led by the world-renowned respiratory KOL Professor Dave Singh, MEU Medical Director. To accelerate drug discovery, MEU have a host of human lung tissue models for target identification and validation studies. The techniques used include cell culture, immunoassays, immunohistochemistry, PCR and flow cytometry.

Meet Micropore Technologies at the UK Pavilion (Hall B, Stand 2348).

Micropore Technologies offers savings in development time, increased yields and simplified operation for those engaged in development and manufacture of parenterals, particularly nano-and micro- sized particles for application in LNPs, PNPs, Polymer microspheres (eg PLGA, PLA), Hydrogels, and many others. We also support our clients with their GMP qualification requirements.

Headquartered in the UK, Micropore has offices in USA and India and has agents in Japan and Australia.

Meet OBN at the UK Pavilion (Hall B, Stand 2348).

OBN’s core purpose is to catalyse success in UK life sciences, and as a not-for-profit member organisation everything we do is focused on helping our Members and the sector to thrive. Our membership of 460+ companies and organisations is spread across the UK with many in the Golden Triangle of Oxford, London and Cambridge. Members include pharma, biotech/medtechs, CXO’s, investors and associated industries (legal, IP, HR, PR etc). Becoming an OBN Member opens the door to a broad range of opportunities to catalyse your growth: via networking/partnering, our purchasing consortium, training and our consulting services. Our largest event is BioTrinity, an annual partnering and investment conference aimed at Series A companies, that attracts the best of life sciences in the UK. So if you are seeking connections in the UK life sciences sector, come and talk to us!

Your success is our success.

Meet ONIX Life Sciences at the UK Pavilion (Hall B, Stand 2348).

ONIX Life Sciences was born twelve years ago in the UK, specializing in regulatory affairs, regulatory operations like CTIS uploads for clinical trials & eCTD publishing. In March 2023 ONIX was acquired by Framework Solutions LLC. Framework Solutions provides Clinical to Commercial Solutions to Biotechnology, and Pharmaceutical Companies with the goal of accelerating customer success. We provide both Strategic and Tactical Solutions in the areas of Medical Affairs, Regulatory, MLR, and Commercialization. These areas are supported by our Technology Group which offers tech-enabled solutions and integrated enterprise help desk/infrastructure support. We have provided services to over 225 clients ranging from Emerging Biotech to Large Pharma. We deliver these services globally with operation centers in North America, Europe, and Asia. For more information on our service offerings, visit our website at www.framesol.com / www.onixls.com and follow our page to stay up to date on the latest news! Transformation through Collaboration.